DZZOM transforms OMICS into intelligence with NETWORK MEDICINE solutions, and makes targeted drug/biomarker R&D cost and time efficient.

ZZOM is a biopharma focused network-sciences company. The Company has been incorporated with the mission to further develop and introduces its disruptive Network Medicine platform services throughout the entire life-cycle of drug/biomarker development and production.

Our proprietary solutions have been developed based on the scientific concepts and results validated by our academic research partners.

Network Medicine

Network Medicine is the rapidly developing field, which applies systems/computational biology and network science methods to drug/biomarker development and production. Networks can be used to visualize and analyze a broad range of biological processes, with nodes in the network representing a biological entity (e.g., gene, protein, enzyme, or disease) and edges representing the relationships between entities (e.g., physical interactions, transcriptional activation, correlations in gene expression levels). This holistic approach is used to relate the complete set of macromolecular interactions between the biological entities and their products to diseases.